OTC:RGBP RGBP just crossed over resistance, retested and continued uptrend setting up for long trade with stop loss below the horizontal line. Presently up 70% since 7/27 earnings Crossing EMA Ribbon shows divergence /momentum Considering a $5 Strike for Jan. '23
OTC:RGBP RGBP has gained 75% since earnings two weeks ago and presently is in a pullback ripe for an entry. Yesterday came the news of an application filing with the USPTO, This should be a catalyst for the resumption of the uptrend. Technical Analysis - Price is sitting at the multisession VWAP. RSI has pulled back a bit , The choppiness index is midrange was...
Specializing in the treatment of cancer and autoimmune diseases, Regen BioPharma Inc. (OTC: RGBP) and (OTC: RGBPP) is a biotech penny stock making notable contributions to the study and treatment of cancer. Currently focused on the development of its NR2F6 therapies, RGBP a an extensive portfolio of patents and its applying for more. Despite trading at a dip, RGBP...
upon review bullish divergence can be seen when combining rsi with price action mac d is coming to retest candles give off sign we''ve hit the bottom huge buy of 30k today descending triangle spotted that may break up or down The Barchart Technical Opinion rating is a 72% Buy with a Weakest short term outlook on maintaining the current direction. Long term...
Price bounced from the lower TL at 0.041 and continues to move up towards a retest of the upper TL of this pennant flag.
Long term indicators fully support a continuation of the trend. Using RSI in combination with price action, bullish divergence had can be seen. The 20sma has bullishly crossed the 200 sma Maybe look for entries if a golden cross forms, The golden cross is a technical chart pattern indicating the potential for a major rally. The golden cross appears on a chart when...
Regen Biopharma, the issued shares are way less than any other OTC pump stock. Great buy in, every news will pump this to the moon.